| Zydus Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532321 |
NSE Symbol : ZYDUSLIFE |
P/E(TTM) : 30.76 |
|
ISIN Demat : INE010B01027 |
Div & Yield% : 0.09 |
EPS(TTM) : 36.54 |
|
Book Value(₹) : 237.30 |
Market Cap(₹Cr) : 112,119.43 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 11,486.40 | 15,117.80 | 10,817.70 | 8,732.60 | 7,835.00 |
| Other Income | 1,667.50 | 696.20 | 1,084.80 | 548.40 | 178.70 |
| Stock Adjustments | 151.60 | 121.10 | 131.70 | -105.10 | 46.90 |
| Total Income | 13,305.50 | 15,935.10 | 12,034.20 | 9,175.90 | 8,060.60 |
| EXPENDITURE : | |||||
| Raw Materials | 3,728.40 | 3,138.00 | 3,284.60 | 3,066.20 | 2,917.10 |
| Power and Fuel Cost | 305.60 | 286.20 | 298.20 | 278.60 | 245.20 |
| Other Manufacturing Expenses | 486.70 | 439.70 | 347.20 | 332.50 | 381.10 |
| Selling and Administration Expenses | 1,805.40 | 1,629.30 | 1,016.80 | 1,040.80 | 956.50 |
| Miscellaneous Expenses | -412.80 | 247.20 | 445.00 | 336.90 | 578.30 |
| Employee Benefit Expenses | 1,966.20 | 1,762.20 | 1,507.50 | 1,321.90 | 1,204.90 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 5,426.00 | 8,432.50 | 5,134.90 | 2,799.00 | 1,777.50 |
| Interest | 482.90 | 463.90 | 390.70 | 278.20 | 134.90 |
| Gross Profit | 4,943.10 | 7,968.60 | 4,744.20 | 2,520.80 | 1,642.60 |
| Depreciation | 561.20 | 523.90 | 504.40 | 488.60 | 478.70 |
| Profit Before Tax | 4,381.90 | 7,444.70 | 4,239.80 | 2,032.20 | 1,163.90 |
| Current Tax | 899.80 | 1,582.50 | 934.30 | 461.80 | 260.20 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -77.70 | 87.30 | -136.00 | 41.20 | 45.80 |
| Reported Net Profit | 3,559.80 | 5,774.90 | 3,441.50 | 1,529.20 | 857.90 |
| Extraordinary Items | -131.38 | 42.40 | 6.10 | -92.27 | -237.64 |
| Adjusted Net Profit | 3,691.18 | 5,732.50 | 3,435.40 | 1,621.47 | 1,095.54 |
| Adjustment below Net Profit | -10.10 | -26.40 | -54.00 | 1.80 | -6.90 |
| Profit/Loss Balance carried down | 18,794.20 | 13,347.60 | 10,567.40 | 9,289.40 | 8,796.90 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1,106.90 | 301.90 | 607.30 | 253.00 | 358.50 |
| P & L Balance carried down | 21,237.00 | 18,794.20 | 13,347.60 | 10,567.40 | 9,289.40 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 100.00 | 1,100.00 | 300.00 | 600.00 | 250.00 |
| Dividend Per Share(Rs) | 1.00 | 11.00 | 3.00 | 6.00 | 2.50 |
| Earnings Per Share-Unit Curr | 35.39 | 57.40 | 34.21 | 15.11 | 8.38 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 235.31 | 210.64 | 156.23 | 134.78 | 129.30 |
| Book Value(Adj)-Unit Curr | 235.31 | 210.64 | 156.23 | 134.78 | 129.30 |
